Ridgewood, NJ, United States of America

Frank A DeBernardis


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank A DeBernardis: Innovator in Tissue Imaging Technology

Introduction

Frank A DeBernardis is a notable inventor based in Ridgewood, NJ (US). He has made significant contributions to the field of medical imaging, particularly in the area of tissue analysis. His innovative work focuses on enhancing the understanding of tissue morphology, which is crucial for diagnosing conditions such as melanoma.

Latest Patents

Frank A DeBernardis holds a patent for a "Three dimensional tissue imaging system and method." This patent involves the use of multispectral digitized images obtained from two or more spectral bands. The technology provides detailed images and information regarding pigmented or differentiated tissue samples at varying depths. The images are transformed to enhance morphological patterns characteristic of melanoma, including statistical properties of the pigment network, image texture, and lesion reflectance. This advancement allows for a better understanding of lesion morphology at different depths. Additionally, the images can be processed to extract features such as blood volume saturation and oxygen saturation, based on differential reflectance or absorption of light.

Career Highlights

Frank A DeBernardis is associated with Mela Sciences, Inc., a company dedicated to developing innovative solutions for skin cancer detection. His work at Mela Sciences has been instrumental in advancing the capabilities of tissue imaging technology.

Collaborations

Some of his notable coworkers include Natalie J Tucker and Austin D Reiter, who have collaborated with him on various projects within the company.

Conclusion

Frank A DeBernardis is a pioneering inventor whose work in tissue imaging technology has the potential to significantly impact the field of dermatology. His innovative patent demonstrates a commitment to improving diagnostic methods for melanoma and other skin conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…